Global Integration And Automation Will Transform Packaging Markets

AN

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

24 Sep 24

Updated

23 Feb 26

Views

106

23 Feb

US$44.36

AnalystConsensusTarget's Fair Value

US$41.50

6.9% overvalued

1Y

59.1%

7D

6.2%

Loading

1Y

59.1%

7D

6.2%

Author's Valuation

US$41.56.9% overvalued

AnalystConsensusTarget Fair Value

Shared on 23 Feb 26

TRS: New CFO Appointment Will Support Long Term Upside Potential

Analysts have kept their $41.50 price target for TriMas unchanged, citing broadly consistent assumptions around the discount rate, revenue growth, profit margin and future P/E as supporting factors for maintaining their view. What's in the News TriMas appointed Paul Swart as Chief Financial Officer, effective December 15, 2025, subject to customary pre employment conditions (Key Developments).

5 views

Shared on 09 Feb 26

TRS: New CFO Appointment Will Support Future Upside Potential

Analysts have maintained their fair value estimate for TriMas at US$41.50, with only small adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E supporting this unchanged target. What's in the News TriMas appointed Paul Swart as Chief Financial Officer, effective December 15, 2025, subject to customary pre employment conditions, succeeding interim CFO and current Board member Teresa M.

3 views

Shared on 25 Jan 26

TRS: Raised Guidance And New CFO Appointment Will Support Future Upside Potential

Analysts have maintained their fair value estimate for TriMas at US$41.50, making only minor adjustments to the discount rate and future P/E assumptions, which reflects a largely unchanged view of the stock's risk and earnings profile. What's in the News TriMas appointed Paul Swart as Chief Financial Officer, effective December 15, 2025, subject to customary pre employment conditions.

6 views

Shared on 11 Jan 26

TRS: Raised Guidance And New CFO Will Support Future Upside Potential

Analysts have kept their fair value estimate for TriMas steady at US$41.50, citing only very small model adjustments in discount rate, revenue expectations, profit margin and future P/E assumptions as the reason for leaving the price target unchanged. What's in the News TriMas appointed Paul Swart as Chief Financial Officer, effective December 15, 2025, succeeding interim CFO and board member Teresa M.

5 views

Shared on 14 Dec 25

TRS: Higher Margins And Share Repurchases Will Drive Future Upside Potential

Analysts have modestly raised their price target on TriMas from 41.50 dollars to 41.50 dollars, reflecting slightly higher long term margin expectations that more than offset a softer near term revenue growth outlook. What's in the News TriMas appointed longtime company veteran Paul Swart as Chief Financial Officer, effective December 15, 2025, succeeding interim CFO and board member Teresa M.

3 views

Shared on 28 Nov 25

TRS: Share Repurchase Completion And Higher Guidance Will Sustain Bullish Momentum

Analysts have maintained their fair value estimate for TriMas at $41.50, with only negligible adjustments to key financial assumptions. This supports a stable outlook.

2 views

Shared on 14 Nov 25

Fair value Decreased 7.78%

TRS: Share Repurchase and Raised Earnings Outlook Will Drive Perceived Undervaluation

The analyst price target for TriMas has recently been lowered from $45.00 to $41.50. Analysts cite revised expectations for revenue growth and profit margins as key factors behind this adjustment.

3 views

Shared on 31 Jul 25

Fair value Increased 13%

Despite a decline in consensus revenue growth forecasts and a rise in TriMas’ future P/E multiple, analysts have increased the fair value price target from $40.00 to $45.00. What's in the News Company completed repurchase of 85,729 shares ($1.84 million), totaling 6,672,784 shares (15.38%) bought back for $184.67 million since buyback began.

1 view

Shared on 01 May 25

Fair value Decreased 0.89%

1 view

Shared on 23 Apr 25

Fair value Decreased 0.15%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

1 view

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

0 views

Shared on 09 Apr 25

Fair value Increased 17%

AnalystConsensusTarget has increased future PE multiple from 13.5x to 15.9x.

0 views

Shared on 02 Apr 25

Fair value Increased 1.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

0 views

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

1 view

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

1 view

Shared on 11 Mar 25

Fair value Decreased 15%

AnalystConsensusTarget has decreased revenue growth from 6.0% to 4.3%, decreased profit margin from 23.2% to 11.7% and increased future PE multiple from 6.6x to 13.5x.

1 view

Valuator

Company Info

Notes

AnalystConsensusTarget Fair Value

US$41.5

6.9% overvalued

Future estimation in

Revenue

Profit Margin

Future PE

Growth p.a.

%

Decrease

Increase

Forecast revenue growth rate

4.27%

Historical revenue growth rate

-6.31%

Packaging revenue growth rate

0.12%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

7.11%

Calculation

US$41.30m

Earnings '29

x

49.64x

PE Ratio '29

=

US$2.05b

Market Cap '29

US$2.05b

Market Cap '29

/

40.63m

No. shares '29

=

US$50.47

Share Price '29

US$50.47 Share Price '29

Discounted to 2026 @ 7.30% p.a.

=

US$40.86

Fair Value '26